ArticleInternal medicine (Tokyo, Japan)2024

Clinical Response of Primary Malignant Pericardial Mesothelioma with Peritoneal Dissemination to Nivolumab.

Shun Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.